PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs)
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Application based on the Transcend FL trial in which Breyanzi showed deep and durable responses and a consistent and well-established safety profile
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
GSK and Flagship to jointly fund up to $150 million upfront
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Phase III ARANOTE trial met primary endpoint, significantly increasing radiological progression-free survival (rPFS) with NUBEQA plus androgen deprivation therapy (ADT) compared to placebo plus ADT
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Subscribe To Our Newsletter & Stay Updated
